RxDoctor Payments Data

Kyle Levitt, DO

Family Medicine · Greensboro, NCNPI 1912427923

Payments from drug & device makers

$1,242in general payments, 2019–2025

Across 39 payments — averaging $31.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$349
  • Dexcom, Inc.$249
  • Abbott$179
  • Amgen$101
  • Bayer$97
  • Lilly USA, LLC$89
  • plus $178 from 9 others

What the payments were for

  • Food & beverage$1,242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,242 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$35,730
Medicare patients
151
Services billed
730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$31,764
JardianceEmpagliflozin19$18,205
ShingrixVaricella-Zoster Ge/As01b/Pf11$2,462
Sumatriptan Succinate11$1,677
Atorvastatin Calcium146$1,583
Rosuvastatin Calcium98$1,316
PaxlovidNirmatrelvir/Ritonavir16$1,282
SynthroidLevothyroxine Sodium11$1,001
Boostrix TdapDiphth,pertuss(Acell),tet Vac13$918
Losartan Potassium73$916
Olmesartan Medoxomil28$831
Albuterol Sulfate HfaAlbuterol Sulfate26$820
Levothyroxine Sodium70$732
Amlodipine Besylate110$535
Gabapentin26$530

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$16$18,20519 claims
GSKShingrix$17$2,46211 claims
AbbVieSynthroid$38$1,00111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →